Manufacturing Execution Systems Market Segmentation:
Deployment Mode Segment Analysis
The hybrid segment in the manufacturing execution systems market is estimated to gain a robust revenue share of 43.0% over the assessed timeline. The segment’s growth is attributed to the expanding oil & gas industry, having a necessity for real-time and big data analytics and management in challenging environments. For instance, till 2022, it was estimated (World Economic Forum) that digital transformation has the potential to generate USD 1.6 trillion value from this industry. Among this amount, USD 1.0 trillion originated solely from digitalization and USD 640.0 billion from societal benefits. It also predicted USD 170.0 billion, USD 10.0 billion, USD 30.0 billion, and USD 430.0 billion to be garnered by customer savings, productivity improvements, water usage reduction, and lower emissions.
End user Segment Analysis
The manufacturing execution systems market from the pharmaceutical segment is set to garner a notable share by the end of 2035. Besides the considerable cost reductions and improved regulatory compliance, MES enables this industry with the functionality to link patient-related data with the production environment inside the facility. In addition, these systems can enhance business procedures in the supply chain and uplift product quality, adding value to the trade and inspiring pharmaceutical leaders to invest more in this sector. To justify this fact, in December 2020, the International Society of Pharmaceutical Engineering calculated the annual net present value (NPV) to be USD 3634.0 in return for an initial investment of USD 50,000 in new MES applications.
Our in-depth analysis of the global manufacturing execution systems market includes the following segments:
|
Offering |
|
|
Deployment Mode |
|
|
Application |
|
|
End user |
|
